Overnight Health Care — Presented by Campaign for Accountability — Momentum builds for federal laws enshrining abortion rights | Missouri lawmakers approve bill banning abortions at 8 weeks | Warren unveils plan to protect abortion rights
Overnight Health Care — Presented by National Taxpayers Union — Trump bans abortion providers from family planning program | White House doesn't back GOP governor on drug imports | HHS declines to provide witnesses for family separations hearing
Welcome to Friday's Overnight Health Care, where there was a lot of health care news today... starting with the much-anticipated Title X rules.
Trump bans abortion providers, referrals from family planning program
The Trump administration's long-awaited changes to the Title X family planning program are out.
The changes: Family planning clinics that provide abortions or refer patients for abortions will not be eligible for certain federal funds.
Under the rule, women's health clinics must be "physically and financially" separate from abortion providers to be eligible for Title X Family Planning grants, which fund organizations providing reproductive health services to low-income women.
Clinics will also not be allowed to refer women to other facilities for abortions or promote or support abortion as a method of family planning.
The context: The changes had been pushed by conservatives and anti-abortion groups as a way to partially defund Planned Parenthood, which serves about 40 percent of Title X patients.
While not all Planned Parenthood clinics provide abortions, some do, and those clinics would become ineligible under the rule, which takes effect 60 days after being published in the federal register.
Democratic response: Democrats, as expected, denounced the move. House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.), for example, called it a "blatant attack on women's health."
White House doesn't back DeSantis on drug importation from Canada
On Wednesday, Florida Gov. Ron DeSantis said he had President Trump's support for drug importation. But on Friday, the White House issued a noncommittal statement declining to give support.
White House deputy press secretary Judd Deere said Trump "has instructed his staff to meet with the governor to learn more details about what he is considering."
"The Administration also looks forward to educating Governor DeSantis on the many policy options the Trump Administration has proposed to reduce costly drug prices for American families," Deere added.
Very different from what DeSantis said Trump said: "I want you to know I spoke personally to President Trump on both Sunday and Monday about this," DeSantis said Wednesday. "He's not only supportive, he's enthusiastic, and he wanted me to tell all of you here today that he supports what we're doing and he will take the necessary executive actions to make sure that we can act under this 2003 law."
Trump's HHS declines to provide witnesses for hearing on family separations
The latest in House Democrats vs. the administration:
The Department of Health and Human Services (HHS) is declining to provide witnesses for a House hearing next week on the administration's treatment of migrant children at the border.
HHS said in a statement that House Democrats did not give them enough time to prepare for the hearing before the House Appropriations health subcommittee, which is scheduled to occur Wednesday and examine the administration's controversial separations of migrant children from their parents at the border.
"Their request did not adhere to the longstanding two-week notification precedent and did not provide adequate time to prepare the witnesses for testimony," said HHS spokeswoman Caitlin Oakley. "HHS has worked to be responsive to the Subcommittee's request and has offered alternative hearing dates and alternative witnesses. Unfortunately, the Subcommittee rejected those offerings."
Context: The back and forth over testifying comes as House Democrats ramp up their oversight of the Trump administration now that they are in the majority, with family separations one of the top areas of focus.
Report: Apps are sharing sensitive data with Facebook without informing users
The latest Facebook controversy involves healthcare:
Several popular apps have been sharing sensitive health data from their users with Facebook, including the timing of their menstrual cycle and their blood pressure, according to a Wall Street Journal analysis published Friday.
The Journal found 11 apps with tens of millions of users among them that were sharing the information with the social network, with little or no disclosure to its users.
Instant Heart Rate: HR Monitor, which the Journal says is the most downloaded heart-rate app on Apple's mobile platform, would send users' heart rates to Facebook immediately after recording it.
The Flo Period & Ovulation Tracker gave Facebook data on users trying to become pregnant or tracking their periods.
What we're reading
Senate inquiry on drug prices echoes landmark hearings held 60 years ago (Kaiser Health News)
Powerful Senate committee launches bipartisan probe into insulin pricing (Stat News)
State by state
Utah officials moved fast to shrink voter-approved Medicaid expansion, documents show (Politico)
'Abortion reversal' policy surfaces in Kentucky legislature (Cincinnati Public Radio)
Maine will ask federal government for more flexibility in Medicaid spending (Portland Press Herald)